| Cunningham, David |
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | Ralinepag, APD811, Placebo | United Therapeutics | PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension, Connective Tissue Diseases, Familial Primary Pulmonary Hypertension, Vascular Diseases, Cardiovascular Diseases, Hypertension, Pulmonary, Lung Diseases, Respiratory Tract Disease | 12/24 | 12/24 | | |
| Recruiting | 3 | 918 | Europe, Canada, Japan, RoW | Zanidatamab, ZW25, JZP598, Tislelizumab, Trastuzumab, Herceptin®, Capecitabine, Oxaliplatin, Cisplatin, 5-Fluorouracil | Jazz Pharmaceuticals, BeiGene, Ltd. | Gastric Neoplasms, Gastroesophageal Adenocarcinoma, Esophageal Adenocarcinoma | 05/25 | 05/26 | | |
| Active, not recruiting | 3 | 240 | Europe, Canada, US, RoW | Brentuximab vedotin, Rituximab, Lenalidomide, Placebo | Seagen Inc. | Diffuse Large B-cell Lymphoma | 05/25 | 04/27 | | |
|
| Recruiting | 3 | 400 | Europe, Canada, Japan, US, RoW | tucatinib, TUKYSA, ONT-380, ARRY-380, PF-07265792, trastuzumab, Herceptin, bevacizumab, Avastin, cetuximab, Erbitux, oxaliplatin, leucovorin, levoleucovorin, fluorouracil | Seagen Inc., Merck Sharp & Dohme LLC | Colorectal Neoplasms | 08/25 | 04/28 | | |
| Active, not recruiting | 2 | 92 | Europe | Gemcitabine, Methylprednisolone, Rituximab, Cisplatin, Lenalidomide | Royal Marsden NHS Foundation Trust, Celgene Corporation | Diffuse Large B-Cell Lymphoma | 02/18 | 08/23 | | |
NCT03892746: Improving SCI Rehabilitation Interventions by Retraining the Brain |
|
|
| Completed | 1/2 | 47 | US | Active tDCS + task oriented practice, Sham tDCS + task oriented practice | The Cleveland Clinic, United States Department of Defense | Cervical Spinal Cord Injruy | 09/24 | 10/24 | | |
| Active, not recruiting | 1/2 | 52 | Europe | Atezolizumab, DKN-01 | Royal Marsden NHS Foundation Trust | Metastatic Esophageal Cancer, Metastatic Gastric Cancer | 12/24 | 09/25 | | |
| Recruiting | 1/2 | 374 | Europe, Canada, Japan, US, RoW | Dazostinag, TAK-676, Pembrolizumab, Platinum, 5-fluorouracil | Takeda, Takeda Development Center Americas, Inc. (TDC Americas) | Solid Neoplasms | 01/26 | 01/26 | | |
| Recruiting | 1/2 | 210 | Europe, US, RoW | CPI-0209 | Constellation Pharmaceuticals | Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma | 12/25 | 03/26 | | |
NCT03840460: A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers |
|
|
| Recruiting | N/A | 200 | Europe | | Royal Marsden NHS Foundation Trust | Pancreatic Adenocarcinoma | 01/23 | 01/23 | | |
NCT03857529: Improving Stroke Motor Control With Non-invasive Brain Stimulation and Functional Electrical Stimulation |
|
|
| Recruiting | N/A | 15 | US | transcranial direct current stimulation and electrical stimulator | MetroHealth Medical Center | Stroke, Rehabilitation, Hand | 08/26 | 08/26 | | |
TRACC, NCT04050345: Tracking Mutations in Cell Free Tumour DNA to Predict Relapse in Early Colorectal Cancer |
|
|
| Recruiting | N/A | 1000 | Europe | | Royal Marsden NHS Foundation Trust | Colorectal Cancer | 07/29 | 07/31 | | |
| Not yet recruiting | N/A | 300 | Europe | biopsy | Royal Marsden NHS Foundation Trust | Adenocarcinoma Esophagus, Adenocarcinoma of the Stomach, Adenocarcinoma - GEJ, Squamous Cell Car. - Esophagus | 05/27 | 05/30 | | |
NCT05866003: tDCS + CCFES-mediated Functional Task Practice for Post-stroke Upper Extremity Hemiplegia |
|
|
| Recruiting | N/A | 63 | US | Active conventional tDCS montage plus CCFES, Active unconventional tDCS montage plus CCFES, Sham tDCS plus CCFES, CCFES with Occupational Therapy | MetroHealth Medical Center | Stroke, Upper Extremity Paresis, Hemiplegia | 04/28 | 04/28 | | |
